P0293: The utility of small bowel capsule endoscopy in Crohn’s Disease – a retrospective cohort studyECCO'25Year: 2025
Authors: Yeo, J.H.(1)*;Raman, K.(1);Willaims, S.(1);Villa, M.(1);Willsmore, J.(1);Bloom, S.(1);McCartney, S.(1);Harrow, P.(1);Kabir, M.(1);Seward, E.(1);Parisi, I.(1);
(1)University College London Hospital, Gastroenterology, London, United Kingdom;
- 1) S Ben-Horin, A Lahat, B Ungar, O Ukashi, D Yablecovitch, M M Amitai, Y Haberman, L Selinger, A Talan-Asher, O Kriger-Sharabi, T Naftali, Y Ron, H Yanai, I Dotan, U Kopylov, R Eliakim, The Israeli IBD Research Nucleus (IIRN), DOP29 Capsule endoscopy-guided proactive treatment versus standard treatment of patients with quiescent Crohn’s Disease: The CURE-CD randomized controlled trial, Journal of Crohn's and Colitis, Volume 18, Issue Supplement_1, January 2024, Pages i125–i126,
P0294: Functional outcomes after primary ileocecal resection for Crohn’s diseaseECCO'25Year: 2025
Authors: Grellier, N.(1)*;Kirchgesner, J.(1);Chafai, N.(2);Nion-Larmurier, I.(1);Debove, C.(2);Bourrier, A.(1);landman, C.(1);Mclellan, P.(1);Sokol, H.(1);Beaugerie, L.(1);Lefèvre, J.H.(2);Seksik, P.(1);
(1)Saint-Antoine Hospital- Assistance Publique Hôpitaux de Paris, Gastroenterology and Nutrition, Paris, France;(2)Saint-Antoine Hospital- Assistance Publique Hôpitaux de Paris, Digestive Surgery, Paris, France;
P0295: Histological healing reduces the risk of relapse in ulcerative colitis: results of a prospective studyECCO'25Year: 2025
Authors: Yzet, C.(1)*;Robert, C.(1);Brazier, F.(1);Meudjo, E.(1);Moreau, C.(1);Chatelain, D.(2);Fumery, M.(1);
(1)Amiens university hospital, Gastroenterology, Amiens, France;(2)Amiens university hospital, Pathology, Amiens, France;
P0296: Comparison of clinical characteristics of Montreal classification group A3 patients with Crohn’s disease in Korea: Results from the Prospective and Retrospective CONNECT StudyECCO'25Year: 2025
Authors: Yoon, J.(1)*;Kim, Y.S.(1);Ye, B.D.(2);Cheon, J.H.(3);Im, J.P.(4);Joo Sung , K.(4);
(1)Kangdong Sacred Heart Hospital- Hallym University College of Medicine, Internal Medicine, Seoul, Korea- Republic Of;(2)Asan Medical Center- University of Ulsan College of Medicine, Gastroenterology and Inflammatory Bowel Disease Center, Seoul, Korea- Republic Of;(3)Yonsei University College of Medicine, Internal Medicine, Seoul, Korea- Republic Of;(4)Seoul National University College of Medicine, Internal Medicine and Liver Research Institute, Seoul, Korea- Republic Of;
P0297: Development of Red Flags Index for Crohn’s Disease in the Korean populationECCO'25Year: 2025
Authors: Kim, O.(1)*;Kim, S.H.(1);Lee, H.J.(1);Im, J.P.(1);Kim, B.G.(1);Kim, J.S.(1);Koh, S.J.(1);
(1)Seoul National University Hospital, Department of Internal Medicine, Seoul, Korea- Republic Of; Gastroenterology
1. Allocca M, Fiorino G, Bonifacio C, et al. Validation of the Red Flags Index for Early Diagnosis of Crohn's Disease: A Prospective Observational IG-IBD Study Among General Practitioners. J Crohns Colitis. 2020;14(4):512-518.
2. Peyrin-Biroulet L, Sandborn W, Sands BE, et al. Development of Red Flags Index for Early Referral of Adults with Symptoms and Signs Suggestive of Crohn’s Disease: An IOIBD Initiative. J Crohns Colitis. 2015;9(8):601-606.
3. Furfaro F, Biamonte E, Vero V, et al. The Earlier You Find, the Better You Treat: Red Flags for Early Diagnosis of Inflammatory Bowel Disease. Diagnostics (Basel). 2023;13(20):3183.
4. Kim JW, Cho YE, Kim JH, et al. Clinical significance of anti-Saccharomyces cerevisiae antibody (ASCA) in Korean patients with Crohn's disease and its relationship to the disease clinical course. Dig Liver Dis. 2007;39(7):610-616.
P0298: Revolutionizing Diagnostics: Evaluating ChatGPT-4's Performance in Ulcerative Colitis Endoscopic AssessmentECCO'25Year: 2025
Authors: Levartovsky, A.(1)*;Albshesh, A.(1);Grinman, A.(1);Shachar, E.(1);Lahat, A.(1);Eliakim, R.(1);Kopylov, U.(1);
(1)Sheba Medical center, Department of Gastroenterology, Tel-aviv, Israel;
P0299: Luminal phenotype of Crohn's disease: the effectiveness of ultrasound compression elastography in the early diagnosis of disease recurrence.ECCO'25Year: 2025
Authors: Iakovlev, A.A.(1)*;Palenyi, A.(2);Nelasov, N.(3);Tarasova, G.(4);Volkov, A.(4);
(1)Rostov State Medical University, Department of Gastroenterology, Rostov-on-Don, Russian Federation;(2)Federal State Budgetary Educational Institution of Higher Education- Rostov State Medical University of the Ministry of Health of Russia, Ultrasonigraphy, Rostov-on-Don, Russian Federation;(3)Federal State Budgetary Educational Institution of Higher Education- Rostov State Medical University of the Ministry of Health of Russia, Ultrasonography, Rostov-on-Don, Russian Federation;(4)Federal State Budgetary Educational Institution of Higher Education- Rostov State Medical University of the Ministry of Health of Russia, Gastroenterology, Rostov-on-don, Russian Federation;
P0300: Ultra-processed food consumption affects body composition in a cohort of italian patients with inflammatory bowel diseaseECCO'25Year: 2025
Authors: Ambrosio, C.(1)*;Compare, D.(1);Sgamato, C.(1);Minieri, S.(1);Zerella, G.(1);Cinque, S.(1);Marchitto, S.A.(1);Nardone, G.(1);
(1)University Federico II, Department of Clinical Medicine and Surgery- Gastroenterology, Naples, Italy; D. Compare, C. Sgamato, C. Ambrosio, S. Minieri, S.A. Marchitto, S. Cinque, G. Zerella, G. Nardone
1.Elly Mertens, Chiara Colizzi, Josè L. Penalvo. Ultra‐processed food consumption in adults across Europe. 61(3):1521-1539.
2.Narula N, Wong ECL, Dehghan M, et al. Association of ultra-processed food intake with risk of inflammatory bowel disease: Prospective cohort study. BMJ 374:n1554
3.Kathy Vagianos, Casandra Dolovich, KelcieWitges, Lesley A.Graff, Charles N. Bernstei. Ultra-Processed Food, Disease Activity, andInflammation in Ulcerative Colitis: The Manitoba Living With IBD Study. The American College of Gastroenterology 2024. 119(6):1102-1109.
4.Carlos A Monteiro, Geoffrey Cannon, Renata B Levy; Jean-Claude Moubarac, Maria LC Louzada, Fernanda Rauber. Ultra-processed foods: what they are and how to identify them. Public Health Nutrition 2018. 936-941
5.Eva Visser, Judith Wellens, Joao Sabino. Ultra-processed foods as a possible culprit for the rising prevalence of inflammatory bowel diseases. Frontiers in Medicine 2022.9:1058373
6.Dinu M, Bonaccio M, Martini D, Madarena MP, Vitale M, Pagliai G, Esposito S, Ferraris C, Guglielmetti M, Rosi A, Angelino D. Reproducibility and validity of a food-frequency questionnaire (NFFQ) to assess food consumption based on the NOVA classification in adults. Int J Food Sci Nutr. 2021 Sep;72(6):861-869
P0301: The Prevalence and Association Between Immune-Mediated Inflammatory Disorders and Inflammatory Bowel DiseaseECCO'25Year: 2025
Authors: Mosli, M.(1);Osman, B.(2)*;Ruckn, A.(1);Alsharif , A.(1); Alghamdi, J.(1); Aldeen, R.(1);Rehal , A.(1);Alsiyoufi , S.(1);Saadah, O.(1);Alsahafi, M.(1);
(1)king abdulaziz university hospital, internal medicine, jeddah, Saudi Arabia;(2)King Abdulaziz University Hospital, Internal medicine department, jeddah, Saudi Arabia;
1-Centers for Disease Control and Prevention. Inflammatory bowel disease (IBD). 2023. Available from: https://www.cdc.gov/ibd/index.htm. Accessed November 20, 2023.
P0302: Outcomes of colectomy-IPAA for UC, is De Novo-CD on the rise?ECCO'25Year: 2025
Authors: Bakkaloglu, O.K.(1)*;Tukek, B.(2);Atay, K.(3);Hatemi, I.(4);Celik, A.F.(4);Erzin, Y.(4);
(1)Kosuyolu High Specialization Education and Research Hospital, Gastroenterology, istanbul, Turkey;(2)Istanbul University Cerrahpasa - Cerrahpasa Medical Faculty, Internal Medicine, Istanbul, Turkey;(3)Mardin Training and Research Hospital, Gastroenterology, Mardin, Turkey;(4)Istanbul University Cerrahpasa - Cerrahpasa Medical Faculty, Gastroenterology, Istanbul, Turkey;
P0303: Evaluation of the Terminal Ileum on Computed Tomography of Patients with Non-Traumatic Acute Abdominal Pain in the Emergency DepartmentECCO'25Year: 2025
Authors: Ergul, M.(1)*;Durak, M.B.(2);Ozturk, O.(1);Cagir, Y.(3);Yuksel, I.(1,4);
(1)Ankara Bilkent City Hospital, Gastroenterology, Ankara, Turkey;(2)Hacettepe University- Faculty of Medicine, Gastroenterology, Ankara, Turkey;(3)Ankara Yildirim Beyazit University- Yenimahalle Training and Research Hospital, Gastroenterology, Ankara, Turkey;(4)Ankara Yildirim Beyazit University- Faculty of Medicine, Gastroenterology, Ankara, Turkey;
P0304: SARS-COV-2 in Colorectal Cancer of IBD PatientsECCO'25Year: 2025
Authors: Boscá Watts, M.M.(1)*;Navarro, S.(2);Rosello, S.(3);Varela, J.M.(4);Gonzalez, S.(4);Fernández, U.(4);Sanahuja, A.(1);Mongort, C.(2);García, T.(4);Suria, C.(1);Tosca, J.(1);Antón, R.(1);Merino, V.(1);Ponce, M.(5);Villagrasa, R.(5);Pla, V.(6);Moro, D.(6);Casado, D.(6);Navarro, D.(7);Pascual, I.(4);
(1)University of Valencia. Hospital Clínico Universitario of Valencia, IBD Unit. Digestive Medicine Department, Valencia, Spain;(2)University of Valencia. INCLIVA. Hospital Clínico Universitario of Valencia, Pathology Department, Valencia, Spain;(3)University of Valencia. INCLIVA. Hospital Clínico Universitario of Valencia, Medical Oncology Department, Valencia, Spain;(4)University of Valencia. Hospital Clínico Universitario of Valencia, Digestive Medicine Department, Valencia, Spain;(5)University of Valencia. Hospital Clínico Universitario of Valencia, Endoscopy Unit. Digestive Medicine Department, Valencia, Spain;(6)University of Valencia. Hospital Clínico Universitario of Valencia, Surgery Department, Valencia, Spain;(7)University of Valencia. Hospital Clínico Universitario of Valencia, Microbiology Department, Valencia, Spain;
2. Durairajan SSK, Singh AK, Saravanan UB, Namachivayam M, Radhakrishnan M, Huang JD, Dhodapkar R, Zhang H. Gastrointestinal Manifestations of SARS-CoV-2: Transmission, Pathogenesis, Immunomodulation, Microflora Dysbiosis, and Clinical Implications. Viruses. 2023 May 24;15(6):1231.
3. Marabotto E, Kayali S, Buccilli S, Levo F, Bodini G, Giannini EG, Savarino V, Savarino EV. Colorectal Cancer in Inflammatory Bowel Diseases: Epidemiology and Prevention: A Review. Cancers (Basel). 2022 Aug 31;14(17):4254.
4. Shafiee S, Cegolon L, Khafaei M, Gholami N, Zhao S, Khalesi N, Moosavian H, Fathi S, Izadi M, Ghadian A, Javanbakht M, Javanbakht A, Akhavan-Sigari R. Gastrointestinal cancers, ACE-2/TMPRSS2 expression and susceptibility to COVID-19. Cancer Cell Int. 2021 Aug 16;21(1):431
P0305: The Choice of Endoscopic Surveillance Strategies for IBD Patients Among Taiwanese Physicians: An Anonymous Questionnaire SurveyECCO'25Year: 2025
Authors: Chen, Y.Y.(1)*;Huang, C.W.(1);Yen, H.H.(1);
(1)Changhua Christian Hospital, Division of Gastroenterology, Changhua, Taiwan;
1. Yen HH, Weng MT, Tung CC, et al. Epidemiological trend in inflammatory bowel disease in taiwan from 2001 to 2015: A nationwide populationbased study. Intest Res 2019;17:54-62.
2.Ng SC, Bernstein CN, Vatn MH, et al. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut 2013;62:630-49.
3.Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet 2017;390:2769-78.
4.Kaplan GG. The global burden of ibd: From 2015 to 2025. Nat Rev Gastroenterol Hepatol 2015;12:720-7.
P0306: Application of 5 different machine-learning approaches to develop an artificial intelligence pathway to predict IBD-associated fatigue: Analysis of 1200 data points in 531 IBD patients.ECCO'25Year: 2025
Authors: Chuah, C.S.(1)*;Whelan, R.(2);Hall, R.(3);Cartlidge, P.(2);Ong, S.(2);Le Saint-Grant, A.(2);Gaya, D.(4);Mowat, C.(3);Seenan, J.P.(5);MacDonald, J.(5);Ho, G.T.(2);
(1)University of Glasgow, School of Infection and Immunity, Glasgow, United Kingdom;(2)University of Edinburgh, Institute of Regeneration and Repair, Edinburgh, United Kingdom;(3)NHS Tayside, Department of Gastroenterology, Dundee, United Kingdom;(4)NHS Greater Glasgow and Clyde, Glasgow Royal Infirmary, Glasgow, United Kingdom;(5)NHS Greater Glasgow and Clyde, Queen Elizabeth University Hospital, Glasgow, United Kingdom;
1. Borren NZ, van der Woude CJ, Ananthakrishnan AN. Fatigue in IBD: epidemiology, pathophysiology and management. Nat Rev Gastroenterol Hepatol. 2019;16(4):247-259. doi:10.1038/s41575-018-0091-9
2. MUSIC IBD Study. Accessed November 11, 2024. https://www.musicstudy.uk/
3. Lundberg S, Lee SI. A Unified Approach to Interpreting Model Predictions. Published online November 25, 2017. doi:10.48550/arXiv.1705.07874
P0307: Application of a machine learning model in the 2+1 central reading paradigm to assess endoscopic severity in ulcerative colitis trialsECCO'25Year: 2025
Authors: Battioui, C.(1);Brodskiy, P.(2);Gottlieb, K.(1)*;Haft-Javaherian, M.(2);Eastman, W.(1);Lehrer, J.(2);Yu, E.(2);Onken, D.(3);Thomason, D.(4);Colucci, D.(4);Reinisch, W.(5);Baxi, S.(4);
(1)Eli Lilly & Company, Clinical Research, Indianapolis, United States;(2)Iterative Health- Inc., Machine Learning, Cambridge, United States;(3)Eli Lilly & Company, Data Science, Indianapolis, United States;(4)Iterative Health- Inc., Data & Insights, Cambridge, United States;(5)Medical University Vienna, Gastroenterology and Hepatology, Vienna, Austria;
Food and Drug Administration. Ulcerative Colitis: Developing Drugs for Treatment [Internet]. 2022 [cited 2024 Oct 17]. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/ulcerative-colitis-developing-drugs-treatment.
Wils, P., Jairath, V., Sands, B. E., Magro, F., Reinisch, W., Rubin, D., . . . & Peyrin‐Biroulet, L. (2023). Comparison of treatment effect between phase 2 and phase 3 trials in patients with inflammatory bowel disease. United European Gastroenterology Journal, 11(8), 797-806.
P0309: Machine learning for predicting Crohn’s disease from routine blood tests years before diagnosis: results from the epi-IIRNECCO'25Year: 2025
Authors: Lev Zion, R.(1)*;Dolev, A.(2);Yuval Bar-Asher, S.(3);Ben-Tov, A.(4,5,6);Ledderman, N.(7);Matz, E.(8);Dotan, I.(9);Turner, D.(3,10,11);Lerner, B.(2);
(1)Shaare Zedek Medical Center, Department of Pediatric Gastroenterology, Jerusalem, Israel;(2)Ben-Gurion University of the Negev, Industrial Engineering and Management, Beersheva, Israel;(3)Shaare Zedek Medical Center, Juliet Keidan Institute of Pediatric Gastroenterology Hepatology and Nutrition, Jerusalem, Israel;(4)Maccabi Healthcare Services, Kahn Sagol Maccabi Research and Innovation Center, Tel-Aviv, Israel;(5)Dana-Dwek Children's Hospital, Pediatrics Department, Tel-Aviv- Israel, Israel;(6)Tel Aviv University, Sackler Faculty of Medicine, Tel-Aviv, Israel;(7)Meuhedet Health Services, Gastroenterology, Tel-Aviv, Israel;(8)Leumit Health Services- Tel-Aviv- Israel, Community Medicine, Tel-Aviv, Israel;(9)Rabin Medical Center, Gastroenterology, Petah Tikva, Israel;(10)The Sackler Faculty of Medicine, Gastroenterology, Tel-Aviv, Israel;(11)The Hebrew University of Jerusalem, Faculty of Medicine, Jerusalem, Israel;
P0310: Intestinal Ultrasound parameters correlate with endoscopic findings in patients with post-operative Crohn’s disease.ECCO'25Year: 2025
Authors: Laoudi, E.(1)*;Chatzinikolaou, M.L.(1);Kokkotis, G.(1);Koutsounas, I.(1);Gizis, M.(1);Chalakatevaki, K.(1); Kitsou, V.(1);Bamias, G.(1);
(1)National and Kapodistrian University of Athens- Sotiria Hospital, GI Unit-3rd Academic Department of Internal Medicine, Athens, Greece;
P0311: Artificial intelligence methods for informative frame detection reduce central reading time and improve disease grading in Ulcerative Colitis clinical trialsECCO'25Year: 2025
Authors: Juhasz, A.(1)*;Delmonte, A.(1);Schaerer, J.(1);Gaither, K.(1);Mishkin, D.(2,3);Vieira, M.(1);
(1)Clario Inc., Medical Imaging, Philadelphia, United States;(2)Atrius Health, Gastroenterology Department, Boston, United States;(3)GI Reviewers LLC, Gastroenterology, Boston, United States;
[1] Jiang X, Luo X, Nan Q, Ye Y, Miao Y, Miao J. Application of deep learning in the diagnosis and evaluation of ulcerative colitis disease severity. Therap Adv Gastroenterol. 2023;16:17562848231215579.
[2] Takabayashi K, Kobayashi T, Matsuoka K, et al. Artificial intelligence quantifying endoscopic severity of ulcerative colitis in gradation scale. Dig Endosc. 2024;36(5):582-590.
P0312: Sarcopenia as a feature of musculoskeletal manifestations of paediatric Crohn’s diseaseECCO'25Year: 2025
Authors: Daichendt, L.(1);Kalia, V.(2);Ross, I.(2);Ali, A.(1);Sawicka, J.(3);Miller, M.(3);Wells, S.(4);Rashmikant Suthar, N.(4);Berard, R.(5);Crowley, E.(6)*;
(1)Schulich School of Medicine & Dentistry- Western University, Paediatrics, London, Canada;(2)Western University, Medical Imaging, London, Canada;(3)Western University, Paediatrics, London, Canada;(4)Children's Hospital- London Health Sciences Centre, Paediatrics, London, Canada;(5)Children's Hospital- London Health Sciences Centre, Paediatric Rheumatology, London, Canada;(6)Children's Hospital- London Health Sciences Centre, Paediatric Gastroenterology, London, Canada;
1. Atlan L, Cohen S, Shiran S, Sira LB, Pratt LT, Yerushalmy-Feler A. Sarcopenia is a Predictor for Adverse Clinical Outcome in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2021;72(6):883-888. doi:10.1097/MPG.0000000000003091
2. Lurz E, Patel H, Lebovic G, et al. Paediatric reference values for total psoas muscle area. J Cachexia Sarcopenia Muscle. 2020;11(2):405-414. doi:10.1002/jcsm.12514
P0313: Bowel wall thickness is not inferior to intestinal ultrasound scores in detecting endoscopic activity in Ulcerative ColitisECCO'25Year: 2025
Authors: Elkot, A.(1)*;Maher, M.(1);Omran, E.(2);Eldesoky, A.E.(1);
(1)Faculty of Medicine-Mansoura University, Internal Medicine Department-Gastroenterology Unit, Mansoura, Egypt;(2)Gastroenterology Surgery Center-Mansoura University, Radiology Department, Mansoura, Egypt;
